2022
DOI: 10.5772/intechopen.108508
|View full text |Cite
|
Sign up to set email alerts
|

Nanostructures in Biosensors: Development and Applications

Abstract: In recent years, there has been significant interest in advanced nanobiosensor technologies with their exceptional properties for real-time monitoring, ultra-sensing, and rapid detection. With relevant experimental data, highly selective and hypersensitive detection of various analytes is possible using biosensors based on nanostructures. In particular, biosensors focus on vital issues such as disease early diagnosis and treatment, risk assessment of quality biomarkers, food-water quality control, and food saf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 65 publications
1
4
0
Order By: Relevance
“…This correlates with the studies by Zhang et al (2014) where cytidine 50-diphosphocholine (PC)-coated AuTSNPs detect C-reactive protein (CRP) in concentrations as low as 0.0033 mg/L, showing the remarkable features of the AuTSNPs and their wide-ranging limits of detection [38]. Detection limits for several other nanobiosensors were reported with ranging limits between 0.8 and 40 ng/mL for gold nanoparticles and 12 pM for Cu nanoclusters, among others [63].…”
Section: Discussionsupporting
confidence: 81%
“…This correlates with the studies by Zhang et al (2014) where cytidine 50-diphosphocholine (PC)-coated AuTSNPs detect C-reactive protein (CRP) in concentrations as low as 0.0033 mg/L, showing the remarkable features of the AuTSNPs and their wide-ranging limits of detection [38]. Detection limits for several other nanobiosensors were reported with ranging limits between 0.8 and 40 ng/mL for gold nanoparticles and 12 pM for Cu nanoclusters, among others [63].…”
Section: Discussionsupporting
confidence: 81%
“…Using these materials and different assembly strategies, we have successfully developed biosensors for a range of target molecules with both clinical and/or industrial relevance, including schemes for the detection of glucose (diabetes) [34], uric acid (pre-eclampsia) [33], sarcosine and creatinine (prostate cancer) [35], galactose (galactosemia) [36], lactate (sepsis) [27], and xanthine (urinary track disease, Lesch-Nyhan Syndrome, and/or meat freshness) [37]. Similar to other work in this area [1,[12][13][14][15][16][17]38], the vast majority of biosensors developed in our lab also employ various NMs to improve S/N and, in virtually every case, utilize additional membrane layers for added selectivity (e.g., polyurethane [34] and chitosan [35], for example). Figure 1 presents two generic LbL-constructed biosensing schemes applied to xanthine (XAN) detection that feature two different NMs in established schemes that result in signal enhancement [34,36].…”
Section: Introductionmentioning
confidence: 93%
“…A popular strategy within biosensor research concerns amperometric sensors that utilize the natural selectivity of immobilized enzymes to directly detect their corresponding substrate or, as in the case of first-generation amperometric biosensors, indirectly detect another target molecule through an enzymatic reaction [ 6 , 7 , 8 , 9 , 10 , 11 ]. Within that realm, a common approach aimed at improving biosensor sensitivity is the incorporation of nanomaterials (NMs), which can range from metallic nanoparticles (NPs) or inorganic NPs to carbon-based NPs, such as carbon nanotubes (CNTs), as functional components of the designed sensing schemes [ 1 , 12 , 13 , 14 , 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…It has been widely employed in environmental monitoring, food science, disease diagnosis, drug discovery, and many more 60,61 . Various nanomaterials, such as quantum dots, gold nanoparticles, and carbon nanostructures, have been introduced into the development of biosensors 62–64 . Still, efficient capture of the biological recognition signal is one of the major challenges in biosensor development.…”
Section: Biomedical Applications Of Dna Origamimentioning
confidence: 99%